The overarching goal of this study is to adapt and feasibility test an evidence-based strengths-based case management (SBCM) intervention for pre-exposure prophylaxis (PrEP) initiation, and examine preliminary efficacy of the intervention comparators (SBCM-PrEP) and (Centers for Disease Control (CDC)-PrEP). Within this context, the Specific Aims are to: 1) Assess client, provider, organization, and structural-level facilitators and barriers to integration of a PrEP focused SBCM (SBCM-PrEP) intervention into routine syringe service program (SSP) practice; 2) Adapt an evidence-based SBCM protocol to provide PrEP intervention services for people who inject drugs (PWID) in SSP sites; and, 3) Examine feasibility, acceptability and preliminary efficacy of the adapted SBCM-PrEP. 80 participants will be randomized into: CDC-PrEP (an in-use PrEP intervention based on CDC guidelines) or SBCM-PrEP.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
80
Multi-session SBCM intervention adapted for PrEP initiation focus
1 session PrEP education following CDC guidelines
University of Kentucky
Lexington, Kentucky, United States
Number of Participants Initiating PrEP
Documented PrEP initiation, measured by dispensed PrEP prescription.
Time frame: 3 months post-baseline
Number of Participants Initiating PrEP
Documented PrEP initiation, measured by dispensed PrEP prescription.
Time frame: 6 months post-baseline
Level of Intervention Engagement Assessed by Session Checklist
5 item Session Checklist completed by Interventionist post-session; range is 5-20, lower scores are higher engagement
Time frame: 8 weeks post-baseline
Level of Intervention Satisfaction Assessed by the IAQ
10 item Intervention Acceptability Questionnaire (IAQ) completed by participants post-intervention; range is 10-50, lower scores are higher acceptability
Time frame: 8 weeks post-baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.